期刊文献+

过氧亚硝基阴离子分解催化剂对衰老大鼠血管舒张功能的保护作用 被引量:1

Peroxynitrite decomposition catalyst improves vascular dysfunction in aging rats
下载PDF
导出
摘要 目的利用过氧亚硝基阴离子(ONOO^-)分解催化剂FeTMPyP探讨衰老大鼠血管舒张功能障碍的可能机制。方法选取雄性SD大鼠,随机分为成年组(3-4月,n=8)、衰老组(18-20月,n=8)及给予FeTMPyP的衰老组(n=6);制备离体胸主动脉环,观察血管舒张功能;采用免疫组织化学法和Westernblot法测定血管组织中可代表ONOO^-生成的标记物3-硝基酪氨酸(3-NT)的表达。结果与成年组大鼠比较,衰老组大鼠胸主动脉环对10^-9-10^-5mol/L累积浓度的内皮依赖性舒张剂乙酰胆碱(ACh)的最大舒张程度显著下降[(29.74%±8.28%)vs(69.52%±5.51%),P〈0.001];对10^-9-10^-5mol/L累积浓度的非内皮依赖性舒张剂硝普钠(SNP)的最大舒张程度也显著下降[(92.01%±3.19%)vs(99.26%±1.33%),P〈0.001]。与成年组大鼠比较,衰老组大鼠血管组织中3-NT蛋白表达增加(P〈0.05)。给予FeTMPyP后,衰老大鼠血管组织中3-NT蛋白表达下降(P〈0.01);抑制ONOO^-的生成后,衰老大鼠胸主动脉环对累积浓度ACh的最大舒张程度显著升高[(65.96%±11.36%)vs(29.74%±8.28%),P〈0.001],对累积浓度SNP的最大舒张程度也显著升高[(98.15%±2.79%)vs(92.01%±3.19%),P〈0.001]。结论FeTMPyP改善了衰老大鼠血管舒张功能,提示ONOO^-可能在衰老大鼠血管功能障碍中起重要作用。 Objective To investigate the possible mechanisms of aging-associated vascular dysfunction by peroxynitrite (ONTO^-) decomposition catalyst FeTMPyP. Methods Male Sprague-Dawlew (SD) rats were randomly divided into three groups: adult group (3-4-month-old, n=8), aging group (18-20-month-old, n=8), and FeTMPyP treatment aging group (n=6). The thoracic aorta was isolated for measurement of vascular diastolic function. Immunohistochemistry and Western-blot were performed to determine the expression of 3-nitrotyrosine (3-NT, a marker of ONTO^- formation) in thoracic aortic arteries. Results (1) Comparing with adult group, the maximal vasodilation in aging rats induced by acetylcholine (ACh, an endothelium-dependent vasodilator, 10^-9 to 10^-5 mol/L) was significantly decreased from (69.52% ± 5.51%) to (29.74% ± 8.28%) (P 〈 0.001); the maximal vasodilation induced by sodium nitroprusside (SNP, an endothelium-independent vasodilator, 10^-9to 10^-5 mol/L) was also decreased from (99.26% ±1.33%) to (92.01% ±3.19%) (P 〈 0.001). (2) The expression of 3-NT in aging vascular tissues was increased (P 〈 0.05) compared with adult group. (3) In aging rats treated with FeTMPyP, the expression of 3-NT was decreased (P 〈 0.01). Moreover, FeTMPyP significantly improved vascular endothelium- dependent and endothelium-independent vasodilations in aging rats. After inhibiting the generation of ONTO^-, ACh-induced maximal vasorelaxation was markedly increased [(65.96% ± 11.36%) vs (29.74% ± 8.28%), P 〈 0.001] and SNP-induced maximal vasodilation was also increased [(98.15% ± 2.79%) vs (92.01% ± 3.19%), P 〈 0.001]. Conclusion FeTMPyP can improve vasodilation dysfunction in aging rats, suggesting that ONTO- may play an important role in aging-related vascular dysfunction.
出处 《中华老年多器官疾病杂志》 2012年第3期217-221,共5页 Chinese Journal of Multiple Organ Diseases in the Elderly
基金 国家自然科学基金项目(No.30973163,30572084) 北京市属高等学校人才强教深化计划“学校创新团队建设计划”项目(No.PHR201106112)
关键词 衰老 血管 血管舒张 3-硝基酪氨酸 大鼠 aging blood vessels vasodilation 3-nitrotyrosine rats
  • 相关文献

参考文献1

二级参考文献31

  • 1Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a “set up” for vascular disease. Circulation 2003; 107: 139–46.
  • 2Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation 2003; 107: 346–54.
  • 3Lakatta EG. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging. Circulation 2003; 107: 490–7.
  • 4Sayer AA, Cooper C. The ageing process. Menopause Int 2000; 6: 55–65.
  • 5Behnke BJ, Delp MD. Aging blunts the dynamics of vasodilation in isolated skeletal muscle resistance vessels. J Appl Physiol 2010; 108: 14–20.
  • 6Nair N, Oka RK, Waring LD, Umoh EM, Taylor CB, Cooke JP. Vascular compliance versus flow-mediated vasodilation: correlation with cardiovascular risk factors. Vasc Med 2005; 10: 275–83.
  • 7Cannon RO 3rd. Role of nitric oxide in cardiovascular disease: focus on the endothelium. Clin Chem 1998; 44: 1809–19.
  • 8Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993; 87: 1468–74.
  • 9Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation 1993; 88: 2541–7.
  • 10F?rstermann U, Boissel JP, Kleinert H. Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J 1998; 12: 773–90.

共引文献7

同被引文献14

  • 1顾俊,王长谦.内皮祖细胞研究进展[J].微循环学杂志,2005,15(4):100-102. 被引量:1
  • 2Cines D, Poliak E, Buck CA,et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders[J]. Blood, 1998, 91(10) :3 527-3 561.
  • 3Li DW, Liu ZQ, Wei J? et al. Contribution of endothelial progenitor cells to neovascularization[J]. Int J Mol Med,2012,30(5) : 1000 -1 006.
  • 4Turko IV,Murad F. Protein nitration in cardiovascular diseases [J]. Pharmacol Rev, 2002,54(4) : 619-634.
  • 5Mayo JN,Beard RS Jr,Price TO, et al. Nitrative stress in cerebral endothelium is mediated by mGluR5 in hyperhomocysteine-mia[J]. J Cereb Blood Flow Metab,2012 ,32(5) :825-834.
  • 6Klassen SS,Rabkin SM. The metalloporphyrin FeTPPS but not by cyclosporin Aantagonizes the interaction of peroxynitrate and hydrogenperoxide on cardiomyocyte cell death [ J ]. Naunyn Schmiedebergs Arch Pharmacol,2009, 379(2): 149-161.
  • 7Liu Xialin, Li Yongjun, Liu Yizhi,et al. Endothelial progenitorcells (EPCs) mobilized and activated by neurotrophic factors may contribute to pathologic neovascularization in diabetic retinopathy [J]. AJP,2010, 176(1):502-515.
  • 8Critser PJ, Yoder MC. Endothelial colony-forming cell role in neoan-giogenesis and tissue repair [ J]. Curr Opin Organ Transplant, 2010,15(1):68-72.
  • 9Wu S, Wang L, Jacoby AM, et al. Ultraviolet B light-induced nitric oxide/peroxynitrite imbalance in keratinocytes-implica-tions for apoptosis and necrosis C J Photochem Photobiol, 2010.,86(2): 389-396.
  • 10Hansson GK. Inflammation, atherosclerosis, and coronary artery disease[J]. N Engl J Med,2005 ,352C16) : 1 685-1 695.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部